Fluticasone prop HFA 110 MCG 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26F5Q58
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,591
Award facts
- Contract value 100% obligated
- $1,591.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,591.08 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of December 3, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its IDC to supply a broad range of pharmaceutical products and medical supplies to federal customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal procurement history demonstrates its capability to fulfill complex medical supply requirements across multiple therapeutic domains through open competition. The DLA Troop Support Medical contract positions AmerisourceBergen as a critical vendor for military healthcare systems, enabling flexible and responsive delivery of both brand-name and generic medications, vaccines, and specialized medical commodities worldwide.
Quick answers
Who was awarded contract SPE2DR26F5Q58?
SPE2DR26F5Q58 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F5Q58 worth?
The government has obligated $1,591 on SPE2DR26F5Q58.
Is contract SPE2DR26F5Q58 an order under another contract?
Yes. SPE2DR26F5Q58 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Q58 competed?
The extent of competition for SPE2DR26F5Q58 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award